bulk cells was compared, there was significantly increased ABCB1 and ABCG2 expression and decreased hOCT1 in the CD34 + cells compared to CML bulk cells. The gene discussed is SLC22A1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.